SCHEMBL2526727

SCHEMBL2526727

CC(=O)N(Cc1ccccc1)C(C)=O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.57
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
CA12 O43570 1/20 0.53
CA9 Q16790 1/20 0.53
TSPO P30536 1/20 0.53
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
ALDH1A1 P00352 3/20 0.50
TSHR P16473 1/20 0.50
ALOX5 P09917 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
AOC3 Q16853 1/20 0.46
RIPK1 Q13546 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11682498 0.91 LMNA (0.53) LMNANPC1RAB9ACA12CA9
SCHEMBL11029320 0.88 ALDH1A1 (0.46) LMNANPC1RAB9ACA12CA9
SCHEMBL11682495 0.88 LMNA (0.50) LMNANPC1RAB9ACA12CA9
SCHEMBL28274515 0.88 CA12 (0.52) LMNANPC1RAB9ACA12CA9
SCHEMBL16215077 0.86 LMNA (0.53) LMNANPC1RAB9ACA12CA9
SCHEMBL6537210 0.86 LMNA (0.53) LMNANPC1RAB9ACA12CA9
SCHEMBL28693395 0.86 LMNA (0.49) LMNANPC1RAB9ACA12CA9
SCHEMBL6536244 0.85 POLB (0.51) LMNANPC1RAB9ACA12CA9
SCHEMBL6647621 0.83 LMNA (0.57) LMNANPC1RAB9ACA12CA9
SCHEMBL29083719 0.83 KMT2A (0.46) LMNANPC1RAB9ACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039669-B2 Catalytic metathesis of secondary amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-10-18 US claimed
US-20090299098-A1 Catalytic Metathesis of Secondary Amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-12-03 US claimed
EP-0736181-A1 AUTOMATED LEAD ASSAY Abbott Laboratories (US) 1996-10-09 EP claimed
WO-1995017679-A1 AUTOMATED LEAD ASSAY ABBOTT LABORATORIES (US) 1995-06-29 WO claimed
CN-117866201-A Nanocellulose-based photo-curing resin and preparation method thereof 广东睿鹏材料科学有限公司 2024-04-12 CN disclosed
US-8039669-B2 Catalytic metathesis of secondary amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-10-18 US disclosed
US-8039669-B2 Catalytic metathesis of secondary amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-10-18 US disclosed
US-8039669-B2 Catalytic metathesis of secondary amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-10-18 US disclosed
US-20090299098-A1 Catalytic Metathesis of Secondary Amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-12-03 US disclosed
US-20090299098-A1 Catalytic Metathesis of Secondary Amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-12-03 US disclosed
US-20090299098-A1 Catalytic Metathesis of Secondary Amides WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-12-03 US disclosed
US-4219626-A Accelerators for radical polymerization reactions with initiators free from peroxide groups BAYER AKTIENGESELLSCHAFT (DE) 1980-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299098-A1 Catalytic Metathesis of Secondary Amides NAAA, NAT1, NAT10 LMNA 2979/4885NPC1 2288/4885RAB9A 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.